Envestnet Asset Management Inc. raised its holdings in CME Group Inc (NASDAQ:CME) by 110.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 209,516 shares of the financial services provider’s stock after buying an additional 110,159 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.06% of CME Group worth $40,669,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also bought and sold shares of CME. Lourd Capital LLC grew its stake in shares of CME Group by 3.5% in the second quarter. Lourd Capital LLC now owns 1,620 shares of the financial services provider’s stock valued at $314,000 after buying an additional 55 shares in the last quarter. Garner Asset Management Corp grew its stake in CME Group by 1.1% in the second quarter. Garner Asset Management Corp now owns 5,200 shares of the financial services provider’s stock worth $1,009,000 after purchasing an additional 55 shares in the last quarter. First Citizens Bank & Trust Co. boosted its holdings in CME Group by 0.3% in the second quarter. First Citizens Bank & Trust Co. now owns 22,092 shares of the financial services provider’s stock worth $4,289,000 after purchasing an additional 59 shares during the period. 6 Meridian increased its stake in CME Group by 2.4% during the second quarter. 6 Meridian now owns 2,700 shares of the financial services provider’s stock valued at $524,000 after purchasing an additional 62 shares during the last quarter. Finally, Contravisory Investment Management Inc. increased its stake in CME Group by 22.9% during the second quarter. Contravisory Investment Management Inc. now owns 344 shares of the financial services provider’s stock valued at $67,000 after purchasing an additional 64 shares during the last quarter. Institutional investors own 84.99% of the company’s stock.
A number of research firms have recently issued reports on CME. Deutsche Bank raised their price target on shares of CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a research report on Friday, August 9th. Zacks Investment Research lowered shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 price objective on the stock. in a research note on Monday, May 27th. Wells Fargo & Co raised their target price on shares of CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a report on Wednesday, July 3rd. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a research note on Friday, August 9th. Finally, Barclays increased their price target on CME Group from $191.00 to $197.00 and gave the stock an “overweight” rating in a research report on Thursday, May 23rd. Three analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $196.85.
In other news, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $217.62, for a total transaction of $544,050.00. Following the completion of the sale, the chief financial officer now owns 30,354 shares in the company, valued at approximately $6,605,637.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink
. Also, insider Derek Sammann sold 6,400 shares of CME Group stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $198.83, for a total value of $1,272,512.00. Following the completion of the transaction, the insider now owns 25,177 shares in the company, valued at $5,005,942.91. The disclosure for this sale can be found here
. Insiders have sold a total of 58,826 shares of company stock valued at $11,921,910 in the last quarter. 1.20% of the stock is currently owned by insiders.
NASDAQ CME traded down $7.49 on Monday, hitting $215.58. The stock had a trading volume of 931,144 shares, compared to its average volume of 1,560,810. The company’s 50-day moving average is $211.18 and its two-hundred day moving average is $190.75. The stock has a market cap of $79.20 billion, a price-to-earnings ratio of 31.61, a P/E/G ratio of 4.93 and a beta of 0.19. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.15. CME Group Inc has a one year low of $161.05 and a one year high of $224.91.
CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.75 by $0.01. CME Group had a return on equity of 9.14% and a net margin of 39.36%. The business had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.27 billion. During the same period in the previous year, the firm posted $1.74 earnings per share. The business’s revenue was up 20.1% on a year-over-year basis. On average, sell-side analysts anticipate that CME Group Inc will post 6.69 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th will be given a dividend of $0.75 per share. The ex-dividend date is Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a yield of 1.39%. CME Group’s dividend payout ratio (DPR) is presently 43.99%.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Read More: How much can an individual set aside as a catch-up contribution?
Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.